✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Shilpa Medicare Ltd.

SHILPAMED

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹6,329 Cr.
P/E
46.11

Shilpa Medicare Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
6,329 Cr
PE
PE
46.11
Prom Holding
Prom Holding
44.23 %
ROE (%)
ROE (%)
3.30
ROCE (%)
ROCE (%)
8.66
Div Yield (%)
Div Yield (%)
0.30
Sales
Sales
1,341 Cr
OPM (%)
OPM (%)
26.64 %
Debt to Equity
Debt to Equity
0.25
View more
Edit Ratio's

About

Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at R… Read more
Low
278
52W Range
High
500
  • Shilpa Medicare
  • Aarti Pharmalabs
  • Supriya Lifescience
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

0 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Pharmaceutical product and services

Product Wise Break-Up - API Business

Location Wise Break-Up - Formulation Business

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Number of ANDA's Filed in Europe
      Source
    • US DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Shilpa Medicare Ltd. Business

    Shilpa Medicare Limited, a global pharmaceutical company based in India, specializes in manufacturing affordable APIs and formulations since 1987, supplying to various regulated markets worldwide.

    Shilpa Medicare major competitors are Aarti Pharmalabs, Supriya Lifescience, Aarti Drugs, SMS Pharmaceuticals, Solara Active Pharma, IOL Chem & Pharma, Morepen Laboratories.
    Market Cap of Shilpa Medicare is ₹6,480 Crs.
    While the median market cap of its peers are ₹2,966 Crs.

    Shilpa Medicare seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar Jun Aug Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Dec
    Conference Call Mar Jun Nov Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Shilpa Medicare Ltd.
    View the discussion on ValuePickr
    Deep Dive Into Shilpa Medicare - Numbers and Narratives
    Shilpa Medicare - DISCUSSION DOCUMENT – TIA CONFERENCE FEB 2024 - Tushar Bohra
    Pharmaceuticals
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material